New drug cenerimod put to the test: will it affect your heart or birth control?
NCT ID NCT04255277
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-stage trial in 97 healthy adults checks if cenerimod, an experimental drug, affects heart rhythm (QT interval) and how it interacts with birth control pills and activated charcoal. Participants receive either placebo, low or high dose cenerimod, or a control drug (moxifloxacin) to measure safety and drug levels. The goal is to gather essential safety data before testing in patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cenerimod
- What this could lead to
- If successful, this study could help determine safe dosing of cenerimod and understand how it interacts with other medications.
- What could go wrong
- This is an early-phase trial in healthy people, not patients. Results may not predict real-world safety or effectiveness in treating disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site 1
Rennes, 35042, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children